Citations

1. Tapson V (2004). Pulmonary embolism. In L Goldman, D Ausiello, eds., Cecil Textbook of Medicine, 22nd ed., vol. 1, pp. 560–568. Philadelphia: Saunders.

2. Kearon C, Hirsh K (2003). Pulmonary embolism section of Venous thromboembolism. In DC Dale, DD Federman, eds., Scientific American Medicine, vol. 1 part 1, chap. 18. New York: WebMD.

3. Rossi SE, et al. (2000). Nonthrombotic pulmonary emboli. American Journal of Roentgenology, 174(6): 1499–1508.

4. American College of Obstetricians and Gynecologists (2000). Prevention of deep vein thrombosis and pulmonary embolism. ACOG Practice Bulletin No. 21. Obstetrics and Gynecology, 96(4): 1–10.

5. Lapostolle F, et al. (2001). Severe pulmonary embolism associated with air travel. New England Journal of Medicine, 345(11): 779–783.

6. Grady D, et al. (2000). Postmenopausal hormone therapy increases risk for venous thromboembolic disease: The heart and estrogen/progestin replacement study. Annals of Internal Medicine, 132(9): 689–696.

7. Task Force on Pulmonary Embolism, European Society of Cardiology (2000). Task force report: Guidelines on diagnosis and management of acute pulmonary embolism. European Heart Journal, 21(16): 1301–1336.

8. Goldhaber SZ, et al. (1997). A prospective study of risk factors for pulmonary embolism in women. JAMA, 277(8): 642–645.

9. Buller HR, et al. (2004). Antithrombotic therapy for venous thromboembolic disease: Seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest, 126(3 Suppl): 401S–428S.

10. Pulmonary Embolism Prevention (PEP) Trial Collaborative Group (2002). Prevention of pulmonary embolism and deep vein thrombosis with low-dose aspirin: Pulmonary embolism prevention (PEP) trial. Lancet, 355(9212): 1295–1302.

11. Abramowicz M, ed. (2006). Advice for travelers. Treatment Guidelines from the Medical Letter, 4(45): 25–34.

12. McManus R, et al. (2006). Thromboembolism, search date September 2005. Online version of Clinical Evidence (15): 1–16.

13. Kearon CK, et al. (2003). Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism. New England Journal of Medicine, 349(7): 631–639.

Other Works Consulted

• Agency for Healthcare Research and Quality (2003). Diagnosis and Treatment of Deep Venous Thrombosis and Pulmonary Embolism. Evidence Report/Technology Assessment No. 68. (AHRQ Publication No.03–E012). Rockville, MD: Agency for Healthcare Research and Quality.

• Kucher N, Tapson VF (2004). Pulmonary embolism. In V Fuster et al., eds., Hurst's The Heart, 11th ed., pp. 1593–1616. New York: McGraw-Hill.

• Tapson VF (2002). Venous thromboembolism. In EJ Topol, ed., Textbook of Cardiovascular Medicine, 2nd ed., pp. 667–684. Philadelphia: Lippincott Williams and Wilkins.